Damora Therapeutics, Inc. (DMRA)
Total Non-Current Liabilities
$974.00K
Quarterly · Period ending: · USD

DMRA Total Non-Current Liabilities
What is total non-current liabilities?
Long-term obligations due beyond one year.
DMRA total non-current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | Total Non-Current Liabilities (USD) | Change |
|---|---|---|
| 81,000 | −94.47% | |
| 1,464,000 | +2,118.22% | |
| 65,999 | −79.88% | |
| 328,000 | −26.79% | |
| 448,000 | −17.19% | |
| 541,000 | +156.40% | |
| 211,000 | — | |
| 0 | — |
Frequently asked questions: DMRA total non-current liabilities
What is Damora Therapeutics, Inc. (DMRA)'s current total non-current liabilities?
Damora Therapeutics, Inc. (DMRA)'s latest reported total non-current liabilities (Quarterly) is $974.00K as of Sep 30, 2026. Long-term obligations due beyond one year.
How much historical total non-current liabilities data is available for DMRA?
Stock Alarm Pro provides 8 dated annual fiscal periods observations for Damora Therapeutics, Inc. (DMRA)'s total non-current liabilities, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare DMRA's total non-current liabilities to peers or set an alert?
You can open DMRA's total non-current liabilities in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on DMRA delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance